COMP <GO>
VRSK vs VRSN // FORWARD P/E MULTIPLE
Verisk Analytics Inc. (NASDAQ) VS. VeriSign Inc. (NASDAQ) • 15-METRIC TALLY: VRSK 9
— VRSN 5
▲ FORWARD P/E MULTIPLE LEADER: VRSK
LAST: $201.50 (+2.65%) • MKT CAP: $25.55B
forward-pe
25.4x
LAST: $308.40 (+0.39%) • MKT CAP: $27.56B
forward-pe
30.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VRSK VS. VRSN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VRSK | VRSN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.90% | 88.20% | -18.30 | VRSN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 53.50% | 40.30% | +13.20 | VRSK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.2x | 25.1x | -8.90 | VRSK | /valuation <GO> |
| Free Cash Flow Yield | 4.80% | 3.89% | +0.91 | VRSK | /fcf-yield <GO> |
| Operating Margin | 43.70% | 67.70% | -24.00 | VRSN | /operating-margins <GO> |
| Net Profit Margin | 29.60% | 49.80% | -20.20 | VRSN | /net-margins <GO> |
| Revenue Growth (YoY) | 6.60% | 6.40% | +0.20 | VRSK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.01% | 0.78% | +0.23 | VRSK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.60 | 0.45 | +5.15 | VRSK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | VRSN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.0 | 58.1 | +1.90 | VRSK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.26 | 1.21 | +0.05 | VRSK | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 25.4x | 30.9x | -5.50 | VRSK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $25.55B | $27.56B | -$2.01B | VRSN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VRSK REV | VRSN REV | VRSK GROSS % | VRSN GROSS % | VRSK FCF | VRSN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.07B | $1.66B | 69.9% | 88.2% | $1.19B | $1.07B |
| FY 2024 | $2.88B | $1.56B | 68.7% | 87.7% | $920.1M | $874.5M |
| FY 2023 | $2.68B | $1.49B | — | — | $940.0M | $786.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VRSK // BETA 1.26
VRSN // BETA 1.21